4,327,164 Shares in KORU Medical Systems, Inc. (NASDAQ:KRMD) Acquired by Topline Capital Management LLC

Topline Capital Management LLC purchased a new position in KORU Medical Systems, Inc. (NASDAQ:KRMD - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 4,327,164 shares of the company's stock, valued at approximately $16,660,000. KORU Medical Systems accounts for 3.1% of Topline Capital Management LLC's holdings, making the stock its 11th biggest position. Topline Capital Management LLC owned approximately 9.44% of KORU Medical Systems at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently modified their holdings of the company. HighTower Advisors LLC lifted its position in shares of KORU Medical Systems by 13.0% during the fourth quarter. HighTower Advisors LLC now owns 43,400 shares of the company's stock worth $167,000 after purchasing an additional 5,000 shares during the last quarter. JPMorgan Chase & Co. increased its position in shares of KORU Medical Systems by 2,770.7% during the fourth quarter. JPMorgan Chase & Co. now owns 17,712 shares of the company's stock worth $68,000 after acquiring an additional 17,095 shares during the period. Virtu Financial LLC bought a new stake in shares of KORU Medical Systems during the fourth quarter valued at approximately $73,000. Y Intercept Hong Kong Ltd purchased a new stake in shares of KORU Medical Systems in the fourth quarter valued at approximately $104,000. Finally, Geode Capital Management LLC grew its stake in KORU Medical Systems by 6.5% in the third quarter. Geode Capital Management LLC now owns 462,128 shares of the company's stock worth $1,262,000 after purchasing an additional 28,323 shares in the last quarter. 58.60% of the stock is owned by institutional investors.

KORU Medical Systems Stock Up 1.5 %

NASDAQ:KRMD traded up $0.04 during midday trading on Wednesday, reaching $2.66. 36,839 shares of the stock traded hands, compared to its average volume of 140,361. The stock has a market capitalization of $122.74 million, a PE ratio of -10.64 and a beta of 0.87. KORU Medical Systems, Inc. has a 12-month low of $1.86 and a 12-month high of $5.05. The company has a debt-to-equity ratio of 0.01, a quick ratio of 2.37 and a current ratio of 2.99. The business has a 50-day moving average of $2.74 and a two-hundred day moving average of $3.37.

Analyst Ratings Changes

Several equities research analysts have weighed in on the company. Lake Street Capital upped their target price on KORU Medical Systems from $4.00 to $5.00 and gave the stock a "buy" rating in a report on Tuesday, January 14th. Craig Hallum increased their target price on shares of KORU Medical Systems from $5.00 to $6.00 and gave the stock a "buy" rating in a report on Friday, January 17th. Piper Sandler restated a "neutral" rating and issued a $4.50 price target on shares of KORU Medical Systems in a report on Friday, February 14th. Finally, B. Riley raised shares of KORU Medical Systems to a "strong-buy" rating in a research note on Thursday, March 13th. One investment analyst has rated the stock with a hold rating, three have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of "Buy" and a consensus target price of $4.70.

KORU Medical Systems Company Profile

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.